SB-277011 GlaxoSmithKline

Current Opinion in Investigational Drugs

Volumn 2, Issue 7, 2001, Pages 946-949

  Remington, G ^a   Kapur, S ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DRUG METABOLITE; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; NEUROLEPTIC AGENT; PROLACTIN; RACLOPRIDE; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; UNCLASSIFIED DRUG;

CATALEPSY; CONTINUOUS INFUSION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG EFFECT; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; EXPERIMENTAL MODEL; IN VIVO STUDY; NONHUMAN; PLASMA CLEARANCE; PSYCHOSIS; RECEPTOR AFFINITY; REVIEW; SCHIZOPHRENIA; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE ANTAGONISTS; DRUG EVALUATION, PRECLINICAL; LIMBIC SYSTEM; NITRILES; QUINOLINES; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROISOQUINOLINES;

EID: 0034920566     PISSN: 09678298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. 1 antagonist SCH-39166 in six cases of acute psychotic states
2. 3 receptor antagonist GR103691 with typical and atypical neuroleptics
3. SmithKline Beecham R&D review meeting, London, UK
4. 4 dopamine receptor antagonist (L745,870) in acutely psychotic inpatients with schizophrenia
5. 3 dopamine receptor antagonists using an ethologically based approach
6. 3 receptor antagonists
7. 2C receptor antagonists
8. Resolving bottlenecks in drug discovery London, UK
9. 27th National Medicinal Chemistry Symposium (Part III) Poster Session II - Highlights, Kansas City, MO, USA
10. 3 receptor antagonist with high oral bioavailability and CNS penetration in the rat
11. 3 receptor antagonist, SB-277011-A
12. 3 receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study
13. 3 receptor antagonist SB-277011 in rats
14. 3 receptor
15. Medicinal Chemistry 16th International Symposium (Part VIID), Bologna, Italy
16. 3 receptor
17. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia
18. 3
19. 3 receptor and its relevance in psychiatry
20. 3 receptor mutant and wild-type mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists
21. 5 dopamine receptor gene in schizophrenia: Identification of a nonsense change and multiple missense changes but lack of association with disease
22. 3 receptor and schizophrenia: Pharmacological, anatomical and genetic approaches
23. 3 dopamine receptor-deficient mice
24. 4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice
25. 3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626
26. 3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626